Table 3:
DMR location |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Relative to gene2 |
||||||||||
Cytogenetic Risk Association1 | Related Genes | Gene Descriptions | Relative to CGI | <10kb upstream of TSS | <2kb upstream of TSS | 5'UTR | Exon | Intron | 3'UTR | <2kb down stream |
Low | HOXA7 | Homeobox A7 | Island | |||||||
Low | MPDU1 | Mannose-P-dolichol utilization defect 1 | Shore | |||||||
Low | AK5 | Adenylate kinase 5 | Overlap | |||||||
Low | FAM179B | Family with sequence similarity 179, member B | Island | |||||||
Low | MEIS1 | Meis homeobox 1 | NA | |||||||
Low | HNRPF | Heterogeneous nuclear ribonucleoprotein F | Overlap | |||||||
Low | TRIM71 | Tripartite motif containing 71 | Overlap | |||||||
Low | CD68 | CD68 molecule | Shore | |||||||
Low | BAHCC1 | BAH domain and coiled-coil containing 1 | Overlap | |||||||
Low | MN1 | Meningioma 1 | NA | |||||||
Mid | NKX2-3 | NK2 homeobox 3 | Island | |||||||
Mid | LRAT | Lecithin retinol acyltransferase | Overlap | |||||||
Mid | C4orf45 | Chromosome 4 open reading frame 45 | Shore | |||||||
Mid | FOXB2 | Forkhead box B2 | Shore | |||||||
Mid | NXPH2 | Neurexophilin 2 | Island | |||||||
Mid | HOXB4 | Homeobox B4 | Shore | |||||||
Mid | SNAP25 | Synaptosomal-associated protein, 25kDa | Island | |||||||
Mid | IRX6 | Iroquois homeobox 6 | Island | |||||||
Mid | NBEA | Neurobeachin | Island | |||||||
Mid | HOXB3 | Homeobox B3 | NA | |||||||
High | TOB2P1 | Transducer of ERBB2, 2 pseudogene 1 | Island | |||||||
High | POU4F1 | POU domain, class 4, transcription factor 1 | Shore | |||||||
High | FOXC1 | Forkhead box C1 | Island | |||||||
High | DCC | Deleted in colorectal carcinoma | Shore | |||||||
High | PCDH10 | Protocadherin 10 isoform 1 precursor | Shore | |||||||
High | PDGFRA | Platelet-derived growth factor receptor alpha | Shore | |||||||
High | MARCKS | Myristoylated alanine-rich protein kinase C | Shore | |||||||
High | PITX1 | Paired-like homeodomain transcription factor 1 | Island | |||||||
High | OTX | Orthodenticle homeobox 1 | Island | |||||||
High | NKX3-2 | NK3 homeobox 2 | Island |
1Comparison with other AML risk groups; only 10 representative DMRs for each group are shown
2Regions showing increased and decreased methylation are marked as pink and green, respectively.